MedTrace Logo

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

NCT03876210 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2019-09-25

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and pharmacokinetics of PK101(fixed-dose combination of PK101-001 and PK101-002) with coadministration of the two separate drugs in healthy volunteers.

Conditions

Interventions

COMBINATION_PRODUCT

PK101

PK101-001 + PK101-002 (combination)

DRUG

PK101-001, PK101-002

coadministration

Sponsors & Collaborators

  • PMG Pharm Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Jang-Hee Hong · Clinical Trials Center, Chungnam National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-12
Primary Completion
2019-07-22
Completion
2019-08-05

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03876210 on ClinicalTrials.gov